These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7195209)

  • 1. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
    Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
    Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF; Bubenheimer P; Roskamm H
    Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
    Wollschläger H; Drexler H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
    Nebel W; Sabin G; Surawitzki G
    Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
    Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
    Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
    Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G
    Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
    Weikl A; Kohlschütter S; Durst OE; Lang E
    Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of AR-L 115 BS with isoprenaline on hemodynamic parameters in the isolated guinea pig heart.
    Schrader J
    Arzneimittelforschung; 1981; 31(1a):183-5. PubMed ID: 7195216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of sulmazol on left ventricular function in congestive cardiomyopathy].
    Maurer E; Klein W; Brandt D
    Arzneimittelforschung; 1983; 33(5):760-3. PubMed ID: 6683555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
    Stauch M; Nechwatal W
    Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic activity of different doses of sulmazole by infusion.
    Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
    Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiments with AR-L 115 BS on skinned cardiac fibers.
    Trube G; Trautwein W
    Arzneimittelforschung; 1981; 31(1a):185-8. PubMed ID: 7195217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
    Benedikter L; Mey T
    Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of AR-L 115 BS compared to caffeine].
    Lichtner R; Wierichs R; Bader H
    Arzneimittelforschung; 1981; 31(1a):193-6. PubMed ID: 6453594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium transport in sarcoplasmic reticulum in the presence of AR-L 115 BS].
    Hasselbach W
    Arzneimittelforschung; 1981; 31(1a):191-3. PubMed ID: 7195219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.